首页> 外文OA文献 >The accuracy of genomic prediction for viral nervous necrosis and vibrosis disease resistance in atlantic cod
【2h】

The accuracy of genomic prediction for viral nervous necrosis and vibrosis disease resistance in atlantic cod

机译:大西洋鳕鱼中病毒性神经坏死和纤维化病抗性的基因组预测准确性

摘要

The objective of this study was to estimate accuracy of genomic prediction for disease resistance to viral nervous necrosis and vibriosis using sparse and genome sequence SNP-data in Atlantic cod. The disease challenge test data of viral nervous necrosis and vibriosis used in this study were obtained from the National Atlantic cod breeding program which is running in Tromsø, Norway and we used disease challenge test data of year-class 2009 for both traits. Disease resistance for both traits was measured as survival at a fixed point in time and assessed as a binary variable. We obtained the result of challenge test data of 707 and 728 individuals for viral nervous necrosis and vibriosis respectively. The individuals came from75 full-sib and half-sib families for both diseases and the number of individuals per family varied from 7 to 20 (average of 9.7) in viral nervous necrosis, and 6 to 10 in vibriosis. On top of pedigree information of 1,743 individuals, three genotype data sets were used in this study, and based on these data sets three different genomic relation matrices were calculated. These were SPARSE8 (genotype data of 283 SNP markers at chromosome 8 of 1,743 individuals), SPARSE GENOME (1,577 individuals’ genotype data of 8,658 SNP markers across the entire genome) and DENSE8 (imputed high density genotypes (759,270 SNPs) of chromosome 8 of 1,743 individuals). The genomic relation matrices were used in the GBLUP with polygenic models to estimate the variance components which were explained by the genomic information, and the genomic estimated breeding values using ASReml software. Fivefold within-family cross validations were carried out by randomly masking 20% of phenotypic records within each family in order to evaluate the accuracy of prediction for the viral nervous necrosis disease trait. Each observation was masked once and 141 phenotypes were masked in the first, second and third cross validation tests, whereas 142 phenotypes were masked in the fourth and fifth cross validation tests. Finally, the phenotypic values of the masked individuals were predicted based on the 566 or 565 phenotypic observations of the unmasked individuals. In the case of a between- families cross validation test, the phenotypic values of 20% of the families were masked at a time and their phenotypic values were predicted from the other families’ phenotypic values. A total of 15 families were masked in each cross validation and the total masked phenotypes were 140, 142, 136, 137 and 153 in the first, second, third, fourth and fifth cross validations respectively. The accuracy of prediction was calculated based on the correlation between the predicted phenotypic values and observed phenotypic values. The results of analysis showed that for the trait disease resistance to viral nervous necrosis, heritability estimates of the trait using the traditional BLUP (h2= 0.359) and GBLUP (SPARSE8) (h2= 0.355) were almost equal. However, GBLUP (DENSE8) (h2= 0.335) and SPARSE GENOME (h2= 0.371) had the lowest and the highest heritability estimates respectively, but these differences were not significant according to their log- likelihood estimates. In the case of vibriosis, our data were not able to distinguish between the genetic variation explained by the genomic information and the pedigree information. The SPARSE GENOME gave a 0.117 heritability estimate by fixing the variance explained by pedigree information at the boundary 0. According to a within-family cross validation test for viral nervous necrosis, the accuracies were estimated as 0.329 in the case of the traditional BLUP and GBLUP (DENSE8) models, but 0.336 in the SPARSE GENOME model. In addition to this, results of between-family cross validation showed that the accuracy of prediction of the DENSE8 (0.15) was less than that of the SPARSE8 (0.16). In our study we found a high heritability of resistance to viral nervous necrosis in Atlantic cod in all models. However, our heritability estimate was lower than the extremely high estimates of other studies in Atlantic cod. The total number of fish, the average number of fish per family, and the model we used in our study could be possible reasons for our relatively lower estimate of heritability for disease resistance to viral nervous necrosis. In our study, the accuracy of prediction of the genomic estimated breeding values using the sparse SNP markers (SPARSE GENOME) did not show a big difference compared with the traditional estimated breeding values, and this could be due to the fact that the phenotypical and genotypical data we used for training was too small to accurately capture the whole fraction of the variance explained by the SNP chip. Moreover, the accuracy of prediction of imputed high density genotypes (DENSE8) of chromosome 8 for disease resistance for viral nervous necrosis was not better than that of SPARSE 8, and this could be because in within- family genomic selection, big segments are inherited together and so the sparse SNPs could be sufficient to detect the chromosome segments. The low heritability estimate of our study to the trait disease resistance for vibriosis is consistent across all studies. However, the accuracy of genomic prediction could not be assessed by cross-validation, since we were not able to distinguish the genetic variance explained by the genomic and pedigree information. In conclusion, for both traits more phenotypic and genotypic data are required in order to properly evaluate the accuracy of prediction of the genomic information.
机译:这项研究的目的是使用大西洋鳕鱼中的稀疏基因组序列和SNP数据,评估基因组预测对病毒性神经坏死和弧菌病抗病性的基因组预测的准确性。这项研究中使用的病毒性神经坏死和弧菌病的疾病挑战测试数据来自于挪威特罗姆瑟市开展的国家大西洋鳕鱼繁殖计划,我们对这两种性状均使用了2009年级的疾病挑战测试数据。将这两种性状的抗病性测量为在固定时间点的存活率,并评估为二元变量。我们分别获得了707和728个人针对病毒性神经坏死和弧菌病的挑战测试数据的结果。来自这两种疾病的75个全同胞和半同胞家庭的个体,每个家庭的病毒性神经坏死人数为7到20(平均9.7),而弧菌病则为6到10。除1,743个个体的谱系信息外,本研究使用了三个基因型数据集,并基于这些数据集计算了三个不同的基因组关系矩阵。这些分别是SPARSE8(1,743位个体的第8号染色体上283个SNP标记的基因型数据),SPARSE GENOME(整个基因组中1,577个个体的8,658个SNP标记的基因型数据)和DENSE8(推算的高密度基因型(759,270个SNP))。 1,743个人)。 GBLUP中的基因组关系矩阵与多基因模型一起用于估算由基因组信息解释的方差成分,并使用ASReml软件估算基因组的育种值。通过随机掩盖每个家庭中20%的表型记录来进行五倍的家庭内部交叉验证,以评估病毒性神经坏死疾病特征预测的准确性。每个观察结果都被掩盖一次,并且在第一,第二和第三次交叉验证测试中掩盖了141个表型,而在第四和第五次交叉验证测试中掩盖了142个表型。最后,根据未掩盖个体的566或565表型观察值,预测被掩盖个体的表型值。对于家庭之间的交叉验证测试,一次掩盖了20%的家庭的表型值,并根据其他家庭的表型值预测了它们的表型值。每次交叉验证中总共掩盖了15个科,在第一次,第二次,第三次,第四次和第五次交叉验证中,掩盖的​​总表型分别为140、142、136、137和153。基于预测表型值和观察到的表型值之间的相关性来计算预测的准确性。分析结果表明,对于性状疾病对病毒神经坏死的抗性,使用传统的BLUP(h2 = 0.359)和GBLUP(SPARSE8)(h2 = 0.355)对该性状的遗传力估计几乎相等。但是,GBLUP(DENSE8)(h2 = 0.335)和稀疏基因组(h2 = 0.371)分别具有最低和最高的遗传力估计值,但根据对数似然估计,这些差异并不显着。在弧菌病的情况下,我们的数据无法区分由基因组信息和谱系信息解释的遗传变异。通过将谱系信息解释的方差固定在边界0处,SPARSE GENOME给出了0.117的遗传力估计值。根据家庭内部针对病毒性神经坏死的交叉验证测试,传统BLUP和GBLUP的准确性估计为0.329。 (DENSE8)模型,但在SPARSE GENOME模型中为0.336。除此之外,家庭间交叉验证的结果表明,DENSE8的预测精度为(0.15)小于SPARSE8的预测精度为(0.16)。在我们的研究中,我们发现在所有模型中,大西洋鳕鱼对病毒神经坏死的抵抗力均具有很高的遗传力。但是,我们对遗传力的估计低于大西洋鳕鱼中其他研究的极高估计。鱼的总数,每个家庭的平均鱼数以及我们在研究中使用的模型可能是我们对病毒性神经坏死的抗病性遗传力估计相对较低的可能原因。在我们的研究中,使用稀疏SNP标记(SPARSE GENOME)预测基因组估计育种值的准确性与传统估计育种值相比没有太大差异,这可能是由于表型和基因型我们用于训练的数据太小,无法准确捕获SNP芯片解释的方差的全部部分。此外,预测8号染色体的估算高密度基因型(DENSE8)对病毒性神经坏死的抗病性的准确性不如SPARSE 8的准确性高,这可能是因为在家族内基因组选择中,大片段是一起遗传的,因此稀疏的SNP可能足以检测染色体片段。在所有研究中,我们对特异性弧菌病抗性的遗传力估计偏低。但是,基因组预测的准确性无法通过交叉验证来评估,因为我们无法区分由基因组和谱系信息解释的遗传方差。总之,对于这两个性状,需要更多的表型和基因型数据,以便正确评估基因组信息预测的准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号